Excel Industries Q3 FY26: Revenue ₹233.5 Cr, PAT ₹8.4 Cr
Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹234Cr
- +19.4% YoY
- −13.3% QoQ
- Net profit
- ₹8Cr
- +33.3% YoY
- −61.9% QoQ
- Margin
- 7%
- +1 pp YoY
- −4 pp QoQ
Guidance rank: #62 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Excel Industries Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9) Q3 FY26 EBITDA (Adjusted): ₹16.9 Cr (Standalone ₹17.1 Cr), +29-30% YoY
From Excel Industries Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9)
- Volume growth in performance solutions driven by capacity expansion in biocides (Page 15)
- Export revenue share: 27.0% of total revenue in Q3 FY26 (Page 5)
- Company plans Capex of Rs. 200–300 Cr over next 3 years for plant upgrades, product innovation, capacity expansion, and technology (Page 15), indirectly supporting growth potential
Profitability & Margins
See what Excel Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Received Environmental Clearance (EC) for capacity increase and new product offerings including Phosphorus Pentasulphide, Diethyldithiophosphoryl Chloride, Diazotization Chemistry platform, Phosphonates, and Pharma capacities.
- Upgraded waste-water treatment capabilities to handle expanded volumes.
- Added volume capabilities for existing and new products at Vizag facility.
- Plan to invest Rs. 200–300 Crores over next three years in plant upgrades, product innovation, capacity expansion, technology.
- Rs. 40-50 Crores per year reserved for ongoing maintenance and improvements.
- Introduced capacities for new products like Sodium Trichloro Pyridinol (NaTCP), polymer additive, and HEDP 4Na.
- Technological advancements and asset maintenance ongoing at Lote and Roha sites.
- PCL3 new plant set up at Lote in 2023.
2 more points from Excel Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Excel Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The slides focus primarily on financial results, revenue, profitability, margins, shareholder returns, key personnel, and ESG principles.
- The presentation presents historical financial performance and sustainability pillars but omits any mention of order backlog or inflow figures.
Excel Industries Ltd — Quarterly revenue & net profit
Excel Industries Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 234 | 196 | +19.4% | 270 | -13.3% |
| Operating profit (EBITDA) | 16 | 12 | +33.3% | 30 | -46.7% |
| Operating margin | 7% | 6% | +1 pp | 11% | -4 pp |
| Profit before tax | 11 | 8 | +37.5% | 27 | -59.3% |
| Net profit (PAT) | 8 | 6 | +33.3% | 21 | -61.9% |
| EPS (₹) | 6.71 | 4.93 | +36.1% | 16.86 | -60.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹275 Cr, net profit ₹29 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Excel Industries's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Excel Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Excel Industries Ltd Q3 FY26 results?
Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9) Q3 FY26 EBITDA (Adjusted): ₹16.9 Cr (Standalone ₹17.1 Cr), +29-30% YoY
What is Excel Industries Ltd share price analysis?
Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 16.9 with a market cap of ₹1,205 Cr. Investors should review the full earnings analysis for detailed insights.
Is Excel Industries Ltd planning capital expenditure?
Received Environmental Clearance (EC) for capacity increase and new product offerings including Phosphorus Pentasulphide, Diethyldithiophosphoryl Chloride, Diazotization Chemistry platform, Phosphonates, and Pharma capacities.
Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
